Concord, CA, United States of America

Bryan H Chang



Average Co-Inventor Count = 4.5

ph-index = 2

Forward Citations = 39(Granted Patents)


Location History:

  • Concord, CA (US) (2004 - 2008)
  • Cambridge, MA (US) (2006 - 2010)

Company Filing History:


Years Active: 2004-2010

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Bryan H Chang

Introduction

Bryan H Chang is a notable inventor based in Concord, CA (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific receptors involved in various diseases. With a total of 5 patents to his name, his work has the potential to impact therapeutic strategies significantly.

Latest Patents

Among his latest patents, Bryan has developed substituted pyrido [2,3-d] pyrimidinone compounds. These low molecular weight, guanidino-containing molecules are capable of acting as MC4-R agonists, which are useful in treating MC4-R mediated diseases. The compounds have specific structures defined in his patent documentation. Additionally, he has created substituted dihydroisoquinolinone compounds, which also act as MC4-R agonists and are beneficial in treating similar diseases.

Career Highlights

Bryan has worked with prominent companies in the pharmaceutical industry, including Novartis Vaccines & Diagnostics and Chiron Corporation. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to innovative research.

Collaborations

Some of his notable coworkers include Daniel T Chu and Rustum S Boyce. Their collaborative efforts have likely enhanced the quality and impact of the research conducted during their time together.

Conclusion

Bryan H Chang's contributions to medicinal chemistry through his innovative patents and collaborations with esteemed colleagues highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in treating diseases related to MC4-R.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…